The store will not work correctly when cookies are disabled.
2,4-dichloro-6H,7H,8H,9H,10H-cyclohepta[b]quinolin-11-amine hydrochloride
ID: ALA4872815
PubChem CID: 164624345
Max Phase: Preclinical
Molecular Formula: C14H15Cl3N2
Molecular Weight: 281.19
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: Cl.Nc1c2c(nc3c(Cl)cc(Cl)cc13)CCCCC2
Standard InChI: InChI=1S/C14H14Cl2N2.ClH/c15-8-6-10-13(17)9-4-2-1-3-5-12(9)18-14(10)11(16)7-8;/h6-7H,1-5H2,(H2,17,18);1H
Standard InChI Key: WPEQYKJGCJNYKO-UHFFFAOYSA-N
Molfile:
RDKit 2D
19 20 0 0 0 0 0 0 0 0999 V2000
13.0527 -11.9330 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
9.3030 -13.1152 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3019 -13.9403 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0148 -14.3521 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0131 -12.7035 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7265 -13.1115 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7272 -13.9362 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4407 -14.3461 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.4351 -12.6985 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4308 -11.8757 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.5903 -12.7040 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
10.0167 -15.1750 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
12.1531 -13.9350 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1489 -13.1055 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7974 -12.5792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8100 -14.4508 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6108 -12.7544 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6221 -14.2580 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9756 -13.5022 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 3 2 0
3 4 1 0
4 7 2 0
6 5 2 0
5 2 1 0
6 7 1 0
7 8 1 0
8 13 2 0
14 9 2 0
9 6 1 0
9 10 1 0
2 11 1 0
4 12 1 0
13 14 1 0
14 15 1 0
13 16 1 0
15 17 1 0
16 18 1 0
17 19 1 0
18 19 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 281.19 | Molecular Weight (Monoisotopic): 280.0534 | AlogP: 4.39 | #Rotatable Bonds: ┄ |
Polar Surface Area: 38.91 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 2 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 6.55 | CX LogP: 4.28 | CX LogD: 4.22 |
Aromatic Rings: 2 | Heavy Atoms: 18 | QED Weighted: 0.73 | Np Likeness Score: -1.00 |
References
1. Gorecki L, Misiachna A, Damborsky J, Dolezal R, Korabecny J, Cejkova L, Hakenova K, Chvojkova M, Karasova JZ, Prchal L, Novak M, Kolcheva M, Kortus S, Vales K, Horak M, Soukup O.. (2021) Structure-activity relationships of dually-acting acetylcholinesterase inhibitors derived from tacrine on N-methyl-d-Aspartate receptors., 219 [PMID:33892271] [10.1016/j.ejmech.2021.113434] |